参考文献/References:
[1] YAO Q,WU X,TAO C,et al.Osteoarthritis:pathogenic signaling pathways and therapeutic targets[J].Signal Transduct Target Ther,2023,8(1):56.
[2] KNIGHTS A J,REDDING S J,MAERZ T.Inflammation in osteoarthritis:the latest progress and ongoing challenges[J].Curr Opin Rheumatol,2023,35(2):128-134.
[3] SANTOS M M,SANTOS A M,NASCIMENTO JUNIOR J A C,et al.The management of osteoarthritis symptomatology through nanotechnology:a patent review[J].J Microencapsul,2023,40(7):475-490.
[4] SZALA D,KOPANSKA M,TROJNIAK J,et al.The role of microRNAs in the pathophysiology of osteoarthritis[J].Int J Mol Sci,2024,25(12):6352.
[5] YADAV K,SAHU K K,SUCHETA,et al.Biomedical applications of nanomaterials in the advancement of nucleic acid therapy:mechanistic challenges,delivery strategies,and therapeutic applications[J].Int J Biol Macromol,2023,241:124582.
[6] YAO L,HAI Q,ZHANG T.The application of nucleic acid nanomaterials in the treatment of mitochondrial dysfunc-tion[J].Curr Drug Metab,2023,24(5):393-403.
[7] YI X,LENG P,WANG S,et al.Functional nanomaterials for the treatment of osteoarthritis[J].Int J Nanomedicine,2024,19:6731-6756.
[8] ZHANG X,LIU Y,XIAO C,et al.Research advances in nucleic acid delivery system for rheumatoid arthritis therapy[J].Pharmaceutics,2023,15(4):1237.
[9] SINGH R P,SRIVASTAVA A K,YANG Y J,et al.Nucleic acid nanotechnology:trends,opportunities and challenges[J].Curr Pharm Biotechnol,2023,24(1):50-60.
[10] LIN Y,GUAN X,SU J,et al.Cell membrane-camouflaged nanoparticles mediated nucleic acids delivery[J].Int J Nanomedicine,2023,18:8001-8021.
[11] KOMAROVA T,ILINA I,TALIANSKY M,et al.Nanoplatforms for the delivery of nucleic acids into plant cells[J].Int J Mol Sci,2023,24(23):16665.
[12] LU J,ZHANG Y,YANG X,et al.Harnessing exosomes as cutting-edge drug delivery systems for revolutionary osteoarthritis therapy[J].Biomed Pharmacother,2023,165:115135.
[13] ZHANG T,CUI W,TIAN T,et al.Progress in biomedical applications of tetrahedral framework nucleic acid-based functional systems[J].ACS Appl Mater Interfaces,2020,12(42):47115-47126.
[14] ZHANG T,TIAN T,LIN Y.Functionalizing framework nucleic-acid-based nanostructures for biomedical applica-tion[J].Adv Mater,2022,34(46):e2107820.
[15] LI Y,LI J,XU S,et al.Tetrahedral framework nucleic acid-based delivery of astaxanthin suppresses chondrocyte pyroptosis and modulates oxidative stress for the treatment of osteoarthritis[J/OL].Adv Healthc Mater,2024[2024-07-28].https://pubmed.ncbi.nlm.nih.gov/38923865/.
[16] SHI S,TIAN T,LI Y,et al.Tetrahedral framework nucleic acid inhibits chondrocyte apoptosis and oxidative stress through activation of autophagy[J].ACS Appl Mater Interfaces,2020,12(51):56782-56791.
[17] SIRONG S,YANG C,TAORAN T,et al.Effects of tetrahedral framework nucleic acid/wogonin complexes on osteoarthritis[J].Bone Res,2020,8:6.
[18] EASTON A,JENSEN M L,WANG C,et al.Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies[J].Mol Ther Nucleic Acids,2022,29:625-642.
[19] YAN W,LI Y,XIE S,et al.Chondrocyte-targeted delivery system of sortase a-engineered extracellular vesicles silencing MMP13 for osteoarthritis therapy[J].Adv Healthc Mater,2024,13(16):e2303510.
[20] GARCIA J P,STEIN J,CAI Y,et al.Fibrin-hyaluronic acid hydrogel-based delivery of antisense oligonucleotides for ADAMTS5 inhibition in co-delivered and resident joint cells in osteoarthritis[J].J Control Release,2019,294:247-258.
[21] LIU X,HU J,NING Y,et al.Aptamer technology and its applications in bone diseases[J].Cell Transplant,2023,32:9636897221144949.
[22] YU Y,LIU M,CHOI V N T,et al.Selection and characteri-zation of DNA aptamers inhibiting a druggable target of osteoarthritis,ADAMTS-5[J].Biochimie,2022,201:168-176.
[23] YAO Y,YANG M,SHI S.Nucleic acid nanomaterials-based therapy for osteoarthritis:progress and prospects[J].Curr Drug Metab,2023,24(5):338-352.
[24] SHANG R,LEE S,SENAVIRATHNE G,et al.microRNAs in action:biogenesis,function and regulation[J].Nat Rev Genet,2023,24(12):816-833.
[25] DIENER C,KELLER A,MEESE E.Emerging concepts of miRNA therapeutics:from cells to clinic[J].Trends Genet,2022,38(6):613-626.
[26] ZHU J,YANG S,QI Y,et al.Stem cell-homing hydrogel-based miR-29b-5p delivery promotes cartilage regeneration by suppressing senescence in an osteoarthritis rat model[J].Sci Adv,2022,8(13):eabk0011.
[27] QIAN Y,CHU G,ZHANG L,et al.M2 macrophage-derived exosomal miR-26b-5p regulates macrophage polarization and chondrocyte hypertrophy by targeting TLR3 and COL10A1 to alleviate osteoarthritis[J].J Nanobiotechnology,2024,22(1):72.
[28] ZHOU W Y,CAI Z R,LIU J,et al.Circular RNA:metabolism,functions and interactions with proteins[J].Mol Cancer,2020,19(1):172.
[29] LIU C X,CHEN L L.Circular RNAs:characterization,cellular roles,and applications[J].Cell,2022,185(12):2016-2034.
[30] ZHAO C,LI X,SUN G,et al.CircFOXO3 protects against osteoarthritis by targeting its parental gene FOXO3 and activating PI3K/AKT-mediated autophagy[J] Cell Death Dis,2022,13(11):932.
[31] MAO G,XU Y,LONG D,et al.Exosome-transported circRNA_0001236 enhances chondrogenesis and suppress cartilage degradation via the miR-3677-3p/Sox9 axis[J].Stem Cell Res Ther,2021,12(1):389.
[32] CHEN Z,HUANG Y,CHEN Y,et al.CircFNDC3B regulates osteoarthritis and oxidative stress by targeting miR-525-5p/HO-1 axis[J].Commun Biol,2023,6(1):200.
[33] ALSHAER W,ZUREIGAT H,AL KARAKI A,et al.si-RNA:mechanism of action,challenges,and therapeutic approaches[J].Eur J Pharmacol,2021,905:174178.
[34] DAI B,ZHU Y,LI X,et al.Blockage of osteopontin-integrin β3 signaling in infrapatellar fat pad attenuates osteoarthritis in mice[J].Adv Sci(Weinh),2023,10(22):e2300897.
[35] YAN Y,LU A,DOU Y,et al.Nanomedicines reprogram sy-novial macrophages by scavenging nitric oxide and silencing CA9 in progressive osteoarthritis[J].Adv Sci(Weinh),2023,10(11):e2207490.
相似文献/References:
[1]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[2]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[3]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[4]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):9.
[5]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[6]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[7]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式
和理论体系[J].中医正骨,2015,27(07):1.
[8]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗
骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):6.
[9]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):15.
[10]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):27.